At the beginning of 2015, the United States President Obama in his state of the Union speech from the national strategic level "medicine", medicine quickly become the focus of the global medical community debate and concern. In February of the same year, Xi Jinping, general secretary of the State Ministry of science and technology and the State Planning Commission, the establishment of China precision medical strategy expert committee. Then, put forward China precise medical plan, and included in the "13th Five-Year" national special major science and technology development, national strategy. Policy on the good news, has greatly stimulated the relevant enterprises and medical institutions to invest human and financial resources to develop precision medical. Industry, investment industry, the industry has been the huge growth of the medical industry's huge space for the development of the industry, the industry venture capital activity, business model and business model innovation thinking emerging. What is the current situation and Prospect of China's precision medical industry? What is the international precision medical high tech field? How to grasp the positive policy under the incremental market, so that precision medicine has become a new growth point of economic and social development?
Under this background, by Fenglin group, Sino American Pharmaceutical Association (SAPA), jointly organized by the Shanghai Marriott exhibition management Limited by Share Ltd "2016 global precision medical (China) summit will be held December 3-4, held in Shanghai, the forum to see a global vision hole edge, local innovation leading the future as the theme and looking at the world, to build the whole industry chain focusing precision medical event. The conference will invite 1000+ from the government regulatory agencies, industry associations, research institutions, hospitals, pharmaceutical companies, life science and Biotech Corp, CRO enterprises, big data solutions provider, investment institutions, law firms, consulting institutions and other senior representatives of China and precise medical market prospects and the latest policies and regulations, big data, advanced precise medical science and technology innovation application and investment opportunities, and Biobank Cohort study, in vitro gene detection and diagnosis of cancer, personalized therapy, cell therapy, new antibody drug development innovation cooperation and other hot topics in-depth international exchange and discussion, to discuss the opportunities and challenges of research and development of precision facing medical innovation. The Committee orchestrated the keynote speech, case analysis, a lot of brainstorming, product performance and customer interaction experience, one to one business, investment and financing projects, such as the form of rich and colorful VIP dinner, you will have the opportunity to listen to the American government leaders read the latest accurate medical policies and regulations, industry status and the opportunities and challenges of well-known academician analysis, scientific research and technology Daniel who were on the forefront of technology development and innovation application, to explore the best individualized treatment and clinical practice of oncology clinicians and investment institutions have a large coffee to explore investment and financing opportunities for cooperation!
"2016 global precision medical (Chinese) summit will be connected to industry and capital, international and domestic market, government guidance and market competition, innovation and industrialization of the close integration of communication platform. Get professional cutting-edge technologies here, to find the most suitable partners, with the most professional customer groups, approached the authority of experts, listen to the master voice, to discuss the prospects for the development of accurate medical industry and challenges. In addition to the Chinese mainland, the General Assembly will be invited from the United States, Europe, Israel, South Korea, Japan, Singapore, Taiwan, Hongkong and other countries and regions, nearly a thousand international wisdom agitation collision. The whole industry chain super deluxe guest speaker lineup, project roadshow financing matchmaking, after the precise medical overseas business trips are the three highlights of this year's forum. The organizing committee sincerely invites you to attend the meeting, Shanghai Grand event!
Guide unit:
Shanghai science and technology committee;
Shanghai Municipal Commission of commerce;
Shanghai Municipal Food and Drug Administration
Host unit:
Shanghai Fenglin health industry (Group) Co., ltd.;
US China Pharmaceutical Development association;
Shanghai Wan Yi exhibition management Limited by Share Ltd
Co organizer:
Shanghai biological and pharmaceutical science and technology industry promotion center;
Shanghai biological and pharmaceutical industry association;
Shanghai medicine clinical research center;
Shanghai medical device industry association;
Shanghai medical quality research center;
Create a flint
Recommended unit:
European Association for radiotherapy and Oncology
Support unit:
International Cancer Research center;
European Union of individual medical;
Chinese American Cancer society;
Chinese American Association of biological medicine;
China Medical Biotechnology Association precision medical branch;
China precision medical industry technology innovation strategic alliance;
National Cancer minimally invasive treatment industry technology innovation strategic alliance
General characteristics:
1000+ professional senior delegates;
500+ senior representatives of research institutions, management of medical institutions, relevant clinical department director of tumor;
100+ of business negotiation;
80+ international renowned speakers;
50 top technology products manufacturers performance and customer interaction experience;
5 academic parallel sub forum focused on: biological sample library and the crowd on column research, gene detection and in vitro diagnosis, personalized clinical treatment of cancer, cell therapy, antibody drug research and development of innovative cooperation;
1 field project financing matchmaking
Pharma Sources Insight January 2025
